Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad406 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Mark Anderson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Research, Abbott Diagnostics Division, Abbott Park, Illinois, USA. Hauptthemen laut MEDLINE: Mpox, Monkeypox. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Abbott Laboratories.
Abstract (Originalsprache)
Background
The 2022 outbreak of the clade IIb monkeypox virus and subsequent global spread lead to an urgent need for the development of high-throughput, sensitive, and reproducible diagnostic tests.
Methods
We developed 3 assays to detect monkeypox virus, 2 (MPXV+ and MPXV) for m2000 RealTime and 1 (MPXV) for Alinity m platforms. Dual targets in E9L and B6R (MPXV+) and J2L and B7R (MPXV) increased mutation resistance. In silico prediction indicates MPXV+ cross-reactivity with orthopox viruses and specific monkeypox virus detection with MPXV. Results m2000 RealTime MPXV+ and MPXV assay sensitivity was determined to be 3.2 plaque-forming units/mL using a reference virus culture diluted into universal transport medium (UTM). Alinity m MPXV lower limit of detection was 200 copies/mL using monkeypox virus plasmids in pooled UTM matrix. m2000 RealTime MPXV+ and MPXV assays were validated with lesion swabs in UTM and 1:1 saliva to UTM mixtures. Commercially available and remnant clinical lesion specimens in UTM were tested with RealTime MPXV+, RealTime MPXV and Alinity m MPXV assays and demonstrated high agreement to known mpox (MPX)-positive specimens.
Conclusions
RealTime MPXV+, RealTime MPXV, and Alinity MPXV are high throughput and sensitive assays used for the detection of monkeypox virus. These assays maybe useful during MPX outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Research, Abbott Diagnostics Division, Abbott Park, Illinois, USA.
- Abbott Pandemic Defense Coalition, Abbott Park, Illinois, USA.
- Abbott Molecular Diagnostics, Des Plaines, Illinois, USA.
- Rush University Medical Center, Chicago, Illinois, USA.
- Montefiore Medical Center, Bronx, NewYork, USA.
ORCID-Profile: Nicholas M Moore
Förderung
- Abbott Laboratories
Zitieren
APA
Anderson, M., Hodges, A., Luk, K. C., Olivo, A., Forberg, K., Meyer, T. V., Strobel, C., Kim, M., Toolsie, D., Moore, N. M., Goldstein, Y., Rodgers, M., Lucic, D., & Cloherty, G. (2024). Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad406
Vancouver
Anderson M, Hodges A, Luk KC, Olivo A, Forberg K, Meyer TV, et al. Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad406
BibTeX
@article{Anderson2024,
author = {Anderson, Mark and Hodges, Austin and Luk, Ka-Cheung and Olivo, Ana and Forberg, Kenn and Meyer, Todd V and Strobel, Carolyn and Kim, Mark and Toolsie, Dan and Moore, Nicholas M and Goldstein, Yitzchak and Rodgers, Mary and Lucic, Danijela and Cloherty, Gavin},
title = {Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad406}
}
EUVIMED